BSE: ZYDUSLIFE - Zydus Lifesciences Limited

Доходность за полгода: +5.49%
Сектор: Healthcare

График акции Zydus Lifesciences Limited


О компании

Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, Latin America, the Asia Pacific, and Africa. The company operates in Pharmaceuticals and Consumer Products segments.

Подробнее
It offers finished dosage human formulations comprising generics, branded generics, and specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; and products in the therapeutic areas of pain management, neurology, dermatology, liver diseases, and other areas. The company also provides consumer wellness products, such as Complan; EverYuth, a range of skincare products; Nycil; Glucon-D glucose powder; Nutralite; Nutralite Doodhshakti, a portfolio of dairy products; and various other products. In addition, the company offers a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, ophthalmology, inflammation, rheumatology, hepatology, infectious disease, etc. Further, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is based in Ahmedabad, India.

Цена ао 1054.35
Выручка 138.12
EBITDA 25.16
P/E 23.93
P/S 2.04
P/BV 2.4
EV/EBITDA 14.03
Число акций ао 1.0122 млрд
Сайт https://zyduslife.com
Див.доход ао 1.3408
Дивиденд ао 6
Валюта inr
ISIN INE010B01027
Sector Health Care
Industry Pharmaceuticals
Валюта отчета inr
Изменение цены за день: -2.32% (1079.35)
Изменение цены за неделю: -5.87% (1120.15)
Изменение цены за месяц: -11.57% (1192.25)
Изменение цены за 3 месяца: -3.19% (1089.1)
Изменение цены за полгода: +5.49% (999.5)
Изменение цены за год: +68.83% (624.5)
Изменение цены за 3 года: +89.73% (555.7)
Изменение цены за 5 лет: +359.51% (229.45)
Изменение цены с начала года: +55.06% (679.95)

Недооценка

Название Значение Оценка
P/S 2.95 6
P/BV 2.53 6
P/E 25.38 6
EV/EBITDA 14.65 7
Итого: 6.13

Эффективность

Название Значение Оценка
ROA, % 7.32 2
ROE, % 11.36 4
Итого: 2.83

Дивиденды

Название Значение Оценка
Div yield, % 1.3408 3.35
DSI 0.8571 8.57
Итого: 4.09

Долг

Название Значение Оценка
Debt/EBITDA 0 10
Итого: 10

Импульс роста

Название Значение Оценка
Доходность Revenue, % 37.72 5
Доходность Ebitda, % 36.84 5
Доходность EPS, % 233.77 10
Итого: 7.2



Руководитель Должность Оплата Год рождения
Dr. Sharvil Pankajbhai Patel MD & Executive Director 262.5M 1979 (45 лет)
Dr. Ganesh Narayan Nayak COO & Executive Director 120M 1955 (69 лет)
Mr. Punit Patel President & CEO of America N/A
Mr. Nitinkumar Dalsukhray Parekh Chief Financial Officer 54.31M
Mr. Arvind Bothra Head of Investor Relations N/A
Mr. Dhaval Narendra Soni Company Secretary & Compliance Officer 2.09M

Адрес: India, Ahmedabad, Zydus Corporate Park - открыть в Google картах, открыть Яндекс картах
Сайт: https://zyduslife.com